MacroGenics: Q3 Earnings Snapshot

ROCKVILLE, Md. (AP) _ MacroGenics Inc. (MGNX) on Thursday reported a loss of $24.8 million in its third quarter.

The Rockville, Maryland-based company said it had a loss of 40 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 49 cents per share.

The biopharmaceutical company posted revenue of $41.7 million in the period, also topping Street forecasts. Three...

READ MORE

ROCKVILLE, Md. (AP) _ MacroGenics Inc. (MGNX) on Thursday reported a loss of $24.8 million in its third quarter.

The Rockville, Maryland-based company said it had a loss of 40 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 49 cents per share.

The biopharmaceutical company posted revenue of $41.7 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $22.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX

Copyright © 2022 . All rights reserved. This website is not intended for users located within the European Economic Area.